clobetasol and Acanthosis-Nigricans

clobetasol has been researched along with Acanthosis-Nigricans* in 3 studies

Other Studies

3 other study(ies) available for clobetasol and Acanthosis-Nigricans

ArticleYear
Acanthosis nigricans at sites of insulin injection in a man with diabetes.
    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2018, 11-26, Volume: 190, Issue:47

    Topics: Acanthosis Nigricans; Administration, Cutaneous; Aged; Clobetasol; Diabetes Mellitus, Type 2; Glucocorticoids; Humans; Hypoglycemic Agents; Injection Site Reaction; Injections, Intralesional; Injections, Subcutaneous; Insulin; Male

2018
A young African woman with hyperglycaemia.
    Australian family physician, 2016, Volume: 45, Issue:4

    Topics: Acanthosis Nigricans; Clobetasol; Congo; Cushing Syndrome; Female; Glucocorticoids; Humans; Hyperglycemia; Hyperpigmentation; Skin Lightening Preparations; Striae Distensae; Young Adult

2016
Porokeratosis of Mibelli induced by topical corticosteroid.
    Journal of cutaneous pathology, 2006, Volume: 33, Issue:7

    [corrected] Prorokeratosis of Mibelli is a chronic disorder characterised by slightly atrophic plaques surrounded by keratotic border.. A 45-year-old with clobetazole propionate ointment for psoriasis over 15 years developed characteristic lesions of porokeratosis Mibelli on the elbows. Histopathological examination revealed the cornoid lamellae located on the edges of the specimen and psoriasiform acanthosis and a spongiotic pustule formation in the center of the specimen; thus, it was suggested as 'psoriasis encircled by porokeratosis'.. Development of porokeratosis may be explained by the local immunosuppressive effect of the prolonged application of the topical steroid.

    Topics: Acanthosis Nigricans; Catheter Ablation; Clobetasol; Glucocorticoids; Humans; Immunocompromised Host; Male; Middle Aged; Porokeratosis; Psoriasis; Treatment Outcome

2006